glenmark

In India, Glenmark offers first nasal spray for adult Covid-19 users

As part of an accelerated approval process, the Mumbai-based pharmaceutical company gained manufacturing-marketing authorisation for Nitric Oxide Nasal Spray from…

3 years ago

Glenmark Pharma gets tentative USFDA nod for generic Regadenoson injection

Glenmark Pharmaceuticals announced on Monday that the country's health regulator has given its generic Regadenoson injectable preliminary approval. The regadenoson…

3 years ago

Glenmark completes Favipiravir (FabiFlu®) after-marketing surveillance in 1000+ COVID-19 patients

Glenmark Pharmaceuticals has announced today the successful conclusion of its Favipiravir (FabiFlu®) post marketing surveillance (PMS) in India study, which…

3 years ago

Glenmark to launch Covid nasal spray in India this year

On Monday, Glenmark Pharmaceuticals announced an exclusive long-term strategic relationship with SaNOtize Research, a Canadian biotech startup, to produce, market,…

3 years ago

Glenmark gets USFDA nod for generic lung cancer drug

Glenmark Pharmaceuticals yesterday said it has received approval from the US health regulator to market Nintedanib capsules, used in the…

3 years ago

Glenmark receives ANDA tentative nod for Nintedanib Capsules, 100mg and 150 mg

Glenmark Pharmaceuticals Ltd has received tentative approval by the United States Food and Drug Administration (USFDA) for Nentenab Capsules, 100…

3 years ago

Glenmark launches Tiogiva, tiotropium bromide dry powder inhaler in UK

Glenmark Pharmaceuticals has launched a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name – Tiogiva,…

3 years ago

Glenmark releases interim data from PMS Study on Favipiravir (FabiFlu)

Glenmark Pharmaceuticals announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India. The…

3 years ago

Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-Release Tablets

Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Theophylline…

3 years ago

Glenmark launches Rufinamide Tablets USP, 200 mg and 400 mg

Glenmark Pharmaceuticals has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel Tablets, 200 mg…

3 years ago